Litha Healthcare Group increases headline earnings

Litha Healthcare Group increases headline earnings per share by 45 percent
Johannesburg, 24 March 2011 - JSE Ltd listed Litha Healthcare Group Limited, a diversified healthcare company with operations in Biotechnology (vaccines), Pharmaceuticals and Medical Devices, announced strong results for the period ended 31 December 2010.

breakingnewspreviewSelwyn Kahanovitz, Litha’s Group Chief Executive said, “We are very pleased with the robust results for the year. We have created an enlarged and diversified group with the acquisitions and are very well positioned to compete even more effectively in the healthcare environment. Our earnings performance was strong, with our headline earnings per share increasing by 45% and earnings per share by 33%.”

Kahanovitz continues, “With the acquisition of the balance of the shares in Litha Healthcare Holdings, the group expects to start extracting cost benefits from the integration and rationalisation of logistics and shared services. We have a focused strategy in place, with a drive to increase scale particularly in our Pharma division.

“On the organic growth side, we will focus in the coming year on bedding down the acquisitions that took place in 2010 and to complete the divisional integration with shared services and logistics.We are positive about the future, with all our divisions profitable and well placed for continued growth.”

Click on the link to view Results Presentation